Ociperlimab Antibody
Ociperlimab (BGB-A1217) is a humanized anti-TIGIT antibody that inhibits the TIGIT-PVR interaction to restore antitumor immunity. It is utilized in preclinical and clinical research for advanced solid tumors, with studies demonstrating its activity in both in vitro cellular assays and in vivo animal models.
Product Specifications
Product Name Alternative
WCD118, WCD-118, Ociperlimab, BGB-A 1217, BGBA1217, BGB-A1217, BGB-A-1217
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
6.22 mg/mL
Purity
99.17% (May vary between batches)
Molecular Weight
145.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
